πŸ‡ΊπŸ‡Έ FDA
Patent

US 9045443

Nitric oxide donor neprilysin inhibitors

granted A61KA61K31/216A61K31/42

Quick answer

US patent 9045443 (Nitric oxide donor neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/216, A61K31/42, A61K31/4245, A61K45/06